People: Ligand Pharmaceuticals Inc (LGND.O)

LGND.O on Consolidated Issue listed on NASDAQ Global Market

64.13USD
17 Apr 2014
Price Change (% chg)

$1.23 (+1.96%)
Prev Close
$62.90
Open
$62.51
Day's High
$66.21
Day's Low
$61.28
Volume
364,140
Avg. Vol
382,519
52-wk High
$80.42
52-wk Low
$23.87

Search Stocks

Berkman, Charles 

Brief Biography

Mr. Charles S. Berkman J.D., serves as Vice President, General Counsel, Secretary of Ligand Pharmaceuticals Inc., since April 2007. Mr. Berkman joined the Company in November 2001 and previously served as Associate General Counsel and Chief Patent Counsel for the Company (and Secretary since March 2007). Prior to joining the Company, Mr. Berkman was an attorney at the international law firm of Baker & McKenzie from November 2000 to November 2001. Before that he served as an attorney at the law firm of Lyon & Lyon from 1993 to November 2000, where he specialized in intellectual property law. Mr. Berkman earned a BS in chemistry from the University of Texas and a JD from the University of Texas School of Law.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
385,283 -- 227,573 685,206

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

John Kozarich

--

John Higgins

2,672,900

Nishan de Silva

1,331,770

Matthew Foehr

1,222,160

Charles Berkman

685,206

Jason Aryeh

--
As Of 30 Dec 2012
Search Stocks